Cargando…

Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles

BACKGROUND: Molecular imaging has generated a great demand to develop targeted contrast agents for MR imaging. MATERIALS AND METHODS: In this study, we synthesized Src homology 2-containing phosphotyrosine phosphatase 2 (SHP2)-targeted and polylactic-co-glycolic acid–-based nanoparticles (NPs), whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, ZhongQian, Qin, JiaLe, Li, TianKuan, Guo, JinHe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751334/ https://www.ncbi.nlm.nih.gov/pubmed/31686812 http://dx.doi.org/10.2147/IJN.S201358

Ejemplares similares

Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles
por: Hu, ZhongQian, et al.
Publicado: (2018)

SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo
por: Hu, ZhongQian, et al.
Publicado: (2017)

Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma
por: Hu, Zhongqian, et al.
Publicado: (2017)

A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma
por: Hu, Zhongqian, et al.
Publicado: (2015)

Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
por: Xu, Xiaozheng, et al.
Publicado: (2021)

Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer
por: Ma, Weike, et al.
Publicado: (2023)

Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations
por: Yu, Zhi-Hong, et al.
Publicado: (2014)

Cardiovascular molecular MR imaging
por: Lamb, H. J., et al.
Publicado: (2007)

Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer
por: Li, Kangan, et al.
Publicado: (2013)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Molecular mechanism of SHP2 activation by PD-1 stimulation
por: Marasco, M., et al.
Publicado: (2020)

Determination of the molecular reach of the protein tyrosine phosphatase SHP-1
por: Clemens, Lara, et al.
Publicado: (2021)

Designing Smart Iron Oxide Nanoparticles for MR Imaging of Tumors
por: Li, Zhenzhen, et al.
Publicado: (2023)

Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2–Induced Gastrulation Defects
por: Jopling, Chris, et al.
Publicado: (2007)

Molecular MR Imaging of Prostate Cancer
por: Kader, Avan, et al.
Publicado: (2020)

Intraarticular injection of SHP2 inhibitor SHP099 promotes the repair of rabbit full-thickness cartilage defect
por: Sun, Ziying, et al.
Publicado: (2022)

The role of tyrosine phosphatase Shp2 in spermatogonial differentiation and spermatocyte meiosis
por: Li, Yang, et al.
Publicado: (2019)

Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling
por: Sun, Ziying, et al.
Publicado: (2022)

Dual PARACEST and (19)F MR molecular imaging of fibrin clots with targeted perfluorocarbon nanoparticles
por: Cai, Kejia, et al.
Publicado: (2009)

Functions of Shp2 in cancer
por: Zhang, Jie, et al.
Publicado: (2015)

Sidestepping SHP2 inhibition
por: Popescu, Bogdan, et al.
Publicado: (2023)

Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022)

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023)

Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
por: Taylor, Julia, et al.
Publicado: (2023)

SHP2 is involved in the occurrence, development and prognosis of cancer
por: Li, Shu, et al.
Publicado: (2023)

Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging
por: Zhao, Wei, et al.
Publicado: (2018)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Skeletal malformation and the SHP-2 pathway
Publicado: (2011)

Shp1 in Solid Cancers and Their Therapy
por: Varone, Alessia, et al.
Publicado: (2020)

PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2
por: Xu, Xiaozheng, et al.
Publicado: (2020)

Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved “backdoor” cysteine
por: Yarnall, Matthew T.N., et al.
Publicado: (2022)

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014)

Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer
por: Piscopo, Leandra, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Determinations of Iron-tannic Molecular Nanoparticles with its Implication in MR Imaging and Enhancement of Liver Clearance
por: Phatruengdet, Thipjutha, et al.
Publicado: (2022)

Unveiling the Molecular Basis of the Noonan Syndrome-Causing Mutation T42A of SHP2
por: Toto, Angelo, et al.
Publicado: (2020)

Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors
por: Luo, Rongshuang, et al.
Publicado: (2021)

Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
por: Bunda, Severa, et al.
Publicado: (2015)

Symmetric Deformable Registration via Learning a Pseudomean for MR Brain Images
por: Sui, Xiaodan, et al.
Publicado: (2021)

Protein-protein interaction between caveolin-1 and SHP-2 is dependent on the N-SH2 domain of SHP-2
por: Park, Hyunju, et al.
Publicado: (2015)

Cryo-Imaging and Software Platform for Analysis of Molecular MR Imaging of Micrometastases
por: Qutaish, Mohammed Q., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_por9s7rkdh4qkm5bodls6an3ga